Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

US VENTURE PARTNERS VIII L P — MAXLINEAR INC insider: 2 transactions · InsiderLens

Home / Insiders / US VENTURE PARTNERS VIII L P

US VENTURE PARTNERS VIII L P

10% owner at Altus Pharmaceuticals Inc. · on record since Jan 31, 2006
10% owner at AtriCure, Inc. · on record since Aug 11, 2006
10% owner at MAXLINEAR INC · on record since Mar 29, 2010
10% owner at LEADIS TECHNOLOGY INC · on record since Jun 15, 2004
10% owner at IMPERVA INC · on record since Nov 15, 2011
10% owner at Guidewire Software, Inc. · on record since Jan 30, 2012
10% owner at OncoMed Pharmaceuticals Inc · on record since Jul 23, 2013

Insider trading activity of US VENTURE PARTNERS VIII L P

Transactions on record: 2; since May 31, 2011

Open-market buys: 0

Open-market sells: 2; $62.3K

Companies traded: 1; last filing May 31, 2011

Figures computed from official regulatory filings — methodology.

Companies where US VENTURE PARTNERS VIII L P has traded

MAXLINEAR INC2 tx · $62.3K · May 31, 2011

Track record of US VENTURE PARTNERS VIII L P

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of US VENTURE PARTNERS VIII L P

Co-insiders of US VENTURE PARTNERS VIII L P

FEDERMAN IRWINAltus Pharmaceuticals Inc. +6
FU WINSTON SAltus Pharmaceuticals Inc. +6
KRAUSZ STEVEN MAltus Pharmaceuticals Inc. +6
LIDDLE DAVID EAltus Pharmaceuticals Inc. +6
PRESIDIO MANAGEMENT GROUP VIII L L CAltus Pharmaceuticals Inc. +6
ROOT JONATHAN DAltus Pharmaceuticals Inc. +6
Rust Christopher JAltus Pharmaceuticals Inc. +6

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

USVP ENTREPRENEUR PARTNERS VIII A L PAltus Pharmaceuticals Inc. +6

USVP ENTREPRENEUR PARTNERS VIII B L PAltus Pharmaceuticals Inc. +6

USVP VIII AFFILIATES FUND L PAltus Pharmaceuticals Inc. +6

YOUNG PHILIP MAltus Pharmaceuticals Inc. +6

Tansey Casey MAtriCure, Inc. +4

Connors Timothy JAltus Pharmaceuticals Inc. +3

PHILLIPS STUART GAtriCure, Inc. +2

WYZGA MICHAEL SAltus Pharmaceuticals Inc. +1

Abruzzo Elsa ChiAtriCure, Inc.

ACCEL INTERNET FUND IV LPIMPERVA INC

ACCEL INVESTORS 2002 LLCIMPERVA INC

ACCEL VIII ASSOCIATES LLCIMPERVA INC

ACCEL VIII LPIMPERVA INC

AHMAD NASERIMPERVA INC

Ahn Sung TaeLEADIS TECHNOLOGY INC

ALDRICH RICHARDAltus Pharmaceuticals Inc.

Alexander Edward EMAXLINEAR INC

ALLEN JOHN KLEADIS TECHNOLOGY INC

Altitude Acquisition Holdco LLCAltus Pharmaceuticals Inc.

ALVAREZ ANTONIO RLEADIS TECHNOLOGY INC

Anquillare Mark VGuidewire Software, Inc.

Arreola JoseLEADIS TECHNOLOGY INC

ARTUSI DANIEL AMAXLINEAR INC

Attie KennethAltus Pharmaceuticals Inc.

Austin TonyaAtriCure, Inc.

Battery Investment Partners VII, LLCMAXLINEAR INC

Battery Partners VII, LLCMAXLINEAR INC

Battery Ventures VII, L.P.MAXLINEAR INC

Bauer David SGuidewire Software, Inc.

Bay Management Co X, LLCGuidewire Software, Inc.

BAY PARTNERS X ENTREPRENEURS FUND LPGuidewire Software, Inc.

BAY PARTNERS X LPGuidewire Software, Inc.

BAZAN NICHOLAS GAtriCure, Inc.

Bear Mary E.G.IMPERVA INC

BEAVER CAROLYNMAXLINEAR INC

BERKELEY RICHARD MAtriCure, Inc.

Berkle SheldonAltus Pharmaceuticals Inc.

BETTENCOURT ANTHONY JIMPERVA INC

BLANK BURKHARDAltus Pharmaceuticals Inc.

BLASING KARENGuidewire Software, Inc.

BNP PARIBAS ARBITRAGE, SAAltus Pharmaceuticals Inc.

Bollesen MichaelMAXLINEAR INC

Boodaei MichaelIMPERVA INC

Company	Filed	Type	Qty	Price	Value · USD	Src
MAXLINEAR INC	May 31, 2011	Sell	-4,621	8.95 USD	$41.4K	SEC
MAXLINEAR INC	May 31, 2011	Sell	-2,342	8.95 USD	$21K	SEC